Suppr超能文献

大鼠和人肝微粒体将普鲁卡因胺代谢为羟胺。

Metabolism of procainamide to a hydroxylamine by rat and human hepatic microsomes.

作者信息

Uetrecht J P, Sweetman B J, Woosley R L, Oates J A

出版信息

Drug Metab Dispos. 1984 Jan-Feb;12(1):77-81.

PMID:6141917
Abstract

We have previously demonstrated that procainamide is oxidized to a reactive metabolite. We speculated that this reactive metabolite might be a hydroxylamine and further that it might be responsible for the syndrome of procainamide-induced lupus. We now report that procainamide is metabolized to a hydroxylamine by rat and human hepatic microsomes. The extent of this metabolic oxidation was quantitated by HPLC after conversion of the hydroxylamine to the more stable nitro derivative of procainamide. Formation of the hydroxylamine required NADPH, active microsomes, and oxygen and was inhibited by carbon monoxide, SKF 525-A, and cimetidine. Formation of the hydroxylamine was also studied as a function of time, microsomal protein concentration, and procainamide concentration.

摘要

我们之前已经证明普鲁卡因胺可被氧化为一种活性代谢产物。我们推测这种活性代谢产物可能是一种羟胺,并且进一步认为它可能是导致普鲁卡因胺诱发狼疮综合征的原因。我们现在报告,大鼠和人肝微粒体可将普鲁卡因胺代谢为一种羟胺。在将羟胺转化为更稳定的普鲁卡因胺硝基衍生物后,通过高效液相色谱法对这种代谢氧化的程度进行了定量。羟胺的形成需要还原型辅酶Ⅱ(NADPH)、活性微粒体和氧气,并且受到一氧化碳、SKF 525 - A和西咪替丁的抑制。还研究了羟胺的形成随时间、微粒体蛋白浓度和普鲁卡因胺浓度的变化情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验